NCT00002024View on ClinicalTrials.gov

Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Cytomegalovirus InfectionsHIV Infections
Interventions
DRUG

Ganciclovir

Trial Locations (1)

94303

Roche Global Development - Palo Alto, Palo Alto

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT00002024 - Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections | Biotech Hunter | Biotech Hunter